These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3862151)

  • 1. Amphetamine response in borderline patients.
    Schulz SC; Schulz PM; Dommisse C; Hamer RM; Blackard WG; Narasimhachari N; Friedel RO
    Psychiatry Res; 1985 Jun; 15(2):97-108. PubMed ID: 3862151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple neuroendocrinological responses in borderline personality disorder patients.
    Kontaxakis V; Markianos M; Vaslamatzis G; Markidis M; Kanellos P; Stefanis C
    Acta Psychiatr Scand; 1987 Nov; 76(5):593-7. PubMed ID: 3124503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced prolactin response to fenfluramine challenge in personality disorder patients is not due to deficiency of pituitary lactotrophs.
    Coccaro EF; Klar H; Siever LJ
    Biol Psychiatry; 1994 Sep; 36(5):344-6. PubMed ID: 7993962
    [No Abstract]   [Full Text] [Related]  

  • 4. The neuroendocrine and behavioral response to dextroamphetamine in normal individuals.
    Dommisse CS; Schulz SC; Narasimhachari N; Blackard WG; Hamer RM
    Biol Psychiatry; 1984 Sep; 19(9):1305-15. PubMed ID: 6149772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amphetamine challenge test in patients with borderline disorder.
    Schulz SC; Cornelius J; Schulz PM; Soloff PH
    Am J Psychiatry; 1988 Jul; 145(7):809-14. PubMed ID: 3381923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borderline and cluster C personality disorders manifest distinct physiological responses to psychosocial stress.
    Aleknaviciute J; Tulen JH; Kamperman AM; de Rijke YB; Kooiman CG; Kushner SA
    Psychoneuroendocrinology; 2016 Oct; 72():131-8. PubMed ID: 27413994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression in borderline patients: a prospective EEG sleep study.
    Reynolds CF; Soloff PH; Kupfer DJ; Taska LS; Restifo K; Coble PA; McNamara ME
    Psychiatry Res; 1985 Jan; 14(1):1-15. PubMed ID: 3857645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].
    Chabrol H; Chouicha K; Montovany A; Callahan S
    Encephale; 2001; 27(2):120-7. PubMed ID: 11407263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affective lability in bipolar disorder and borderline personality disorder.
    Reich DB; Zanarini MC; Fitzmaurice G
    Compr Psychiatry; 2012 Apr; 53(3):230-7. PubMed ID: 21632042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in EEG mean frequency associated with anxiety and with amphetamine challenge in BPD.
    Cornelius JR; Schulz SC; Brenner RP; Soloff PH; Ulrich RF
    Biol Psychiatry; 1988 Sep; 24(5):587-94. PubMed ID: 3048424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG sleep evaluation of depression in borderline patients.
    McNamara E; Reynolds CF; Soloff PH; Mathias R; Rossi A; Spiker D; Coble PA; Kupfer DJ
    Am J Psychiatry; 1984 Feb; 141(2):182-6. PubMed ID: 6691476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive response to physostigmine challenge in borderline personality disorder patients.
    Steinberg BJ; Trestman R; Mitropoulou V; Serby M; Silverman J; Coccaro E; Weston S; de Vegvar M; Siever LJ
    Neuropsychopharmacology; 1997 Oct; 17(4):264-73. PubMed ID: 9326751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and 'well-state' bipolar patients.
    Nurnberger JI; Gershon ES; Simmons S; Ebert M; Kessler LR; Dibble ED; Jimerson SS; Brown GM; Gold P; Jimerson DC; Guroff JJ; Storch FI
    Psychoneuroendocrinology; 1982; 7(2-3):163-76. PubMed ID: 6891082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences.
    Zimmerman M; Martinez JH; Morgan TA; Young D; Chelminski I; Dalrymple K
    J Clin Psychiatry; 2013 Sep; 74(9):880-6. PubMed ID: 24107761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing depression in borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM
    J Clin Psychiatry; 1987 Apr; 48(4):155-7. PubMed ID: 3558327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender determines cortisol and alpha-amylase responses to acute physical and psychosocial stress in patients with borderline personality disorder.
    Inoue A; Oshita H; Maruyama Y; Tanaka Y; Ishitobi Y; Kawano A; Ikeda R; Ando T; Aizawa S; Masuda K; Higuma H; Kanehisa M; Ninomiya T; Akiyoshi J
    Psychiatry Res; 2015 Jul; 228(1):46-52. PubMed ID: 25979467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is bulimia associated with borderline personality disorder? A controlled study.
    Pope HG; Frankenburg FR; Hudson JI; Jonas JM; Yurgelun-Todd D
    J Clin Psychiatry; 1987 May; 48(5):181-4. PubMed ID: 3571171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there borderlines in Britain? A cross-validation of US findings.
    Kroll J; Carey K; Sines L; Roth M
    Arch Gen Psychiatry; 1982 Jan; 39(1):60-3. PubMed ID: 7055409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An empirical study of psychosis in borderline personality disorder.
    Pope HG; Jonas JM; Hudson JI; Cohen BM; Tohen M
    Am J Psychiatry; 1985 Nov; 142(11):1285-90. PubMed ID: 4061687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis in borderline personality disorder.
    Jonas JM; Pope HG
    Psychiatr Dev; 1984; 2(4):295-308. PubMed ID: 6396640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.